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of our method for measuring clinical disintegration time. The clini-
cal disintegration time of the 17 ODT products was between 17.6 
and 33.8 seconds in the clinical trial conducted with healthy adult 
volunteers. In the measurement of the amounts of water required for 
ingesting CTs and ODTs, no significant difference was observed in 
the amount of water required for ingesting CTs and ODTs among 
the 3 groups. The amount of water required for ingesting ODTs was 
significantly lesser than that required for ingesting CTs.
Conclusion: This study demonstrates that all the tested products, 
which are clinically available in Japan, exhibit good disintegration 
and that the disintegration time varies by the product. This study 
also showed that the amount of water required for ingesting ODTs 
is lower than that required for ingesting CTs.
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Introduction: Patients admitted to internal medicine wards receive 
a large number of drugs and are at risk of drug-related problems 
(DRPs) that may be associated with morbidity and mortality. In a 
French study, the in-hospital incidence rate of adverse drug reactions 
in internal medicine was 10.1 per 1000 patient-days and 80% of 
them could be considered preventable. The aim of the present study 
was to detect suboptimal drug use in 2 pilot wards of a general 
internal medicine service and to offer a pharmacologic and pharma-
ceutical evaluation to improve drug prescription.
Patients (or Materials) and Methods: This was a prospective study 
conducted during 6 months in 2 internal medicine wards in a 2000-
bed university hospital. Physician rounds were attended once every 
other week in each ward by a clinical pharmacist and a clinical 
pharmacologist. All patients met during the physician rounds were 
included. Prescriptions were analyzed through an assessment grid to 
detect DRPs. Treatment optimizations were suggested to prescrib-
ers during the round. The main outcome measures were: (1) most 
frequent DRPs and involved drugs or drug classes; (2) types of inter-
vention required: no intervention, verbal suggestion of treatment 
optimization, or specialized written consultation; and (3) acceptance 
rate by prescribers.
Results: A total of 145 patients (mean age, 68 [21–99]; 48% female) 
were included with 1523 prescriptions (mean, 10.6 [0–21] prescrip-
tions per patient). A total of 383 DRPs were identified (mean, 2.6 
[0–12] DRPs per patient). The most frequently identified DRPs were: 
(1) drug interactions (21%); (2) untreated indications (18%); (3) 
overdosage (16%); and (4) drug used without a valid indication 
(10%). The most frequently involved drugs or drug classes were: (1) 
for drug interactions: tramadol, antidepressants, and acenocoumarol; 
(2) for untreated indications: calcium-vitamin D, statins, and aspirin; 
(3) for overdosage: proton pump inhibitors and paracetamol; and (4) 
for drug used without a valid indication: proton pump inhibitors and 
aspirin. Fifty-one percent of the identified DRPs were considered as 
clinically not relevant and were not reported to the prescribers, 42% 
were reported with a verbal suggestion of treatment optimization, 
and 7% were considered as complex and triggered a specialized writ-
ten consultation by a clinical pharmacologist. Suggestions of treat-
ment optimization were accepted by prescribers in 84% of cases. 
Accepted suggestions were applied by physicians in 64% of cases.
Conclusion: The most frequently identified DRPs were drug interac-
tions. One half of the identified DRPs required a suggestion of treat-
ment optimization, which was accepted and applied by prescribers 
in most cases.
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Introduction: The Drug Burden Index (DBI), a novel pharmacologic risk 
assessment tool that measures an individual’s total exposure to anticho-
linergic and sedative medicines, has been associated with impaired physi-
cal function, falls, and increased hospitalization in older adults. Aims: (1) 
To develop software which calculates and generates reports on DBI; (2) 
to use published case study data to test the DBI software for accuracy; 
and (3) to test the software for usability and functionality.
Patients (or Materials) and Methods: Microsoft Access 2010 was 
used to build and design The DBI Calculator©. Twenty-five drug regi-
mens from patient case studies published in the Australian Journal 
of Pharmacy (August 2010 to August 2012) were used to compare 
DBI scores computed using The DBI Calculator© and those com-
puted manually (gold standard). Cohen’s Kappa statistics were used 
to calculate the degree of concordance between manual and auto-
mated DBI scores. Ten pharmacists accredited to perform medication 
management reviews were randomly selected from online pharmacist 
contact lists to participate in the usability testing. The usability test 
was developed from previous usability studies. Participants were 
timed to perform a DBI calculation with the software based on a drug 
regimen from the case studies. A survey was used to rate the interface, 
functionality, clinical applications, and satisfaction of software.
Results: (1) The software has been designed to allow for ease of 
uploading onto a secured, de-identified, password-protected website. 
The user enters patient data and clicks “Calculate DBI” and immedi-
ately receives a report of the DBI with information on the significance 
of the calculation for the patient. (2) Results indicate good agreement 
between the software and manual calculation (Cohen’s Kappa 0.95) 
among the 16/25 drug regimens from patient case studies tested with 
DBI > 0. (3) During usability testing, 90% of respondents were satis-
fied with the software and agreed the content in the software was 
accurate. The usability study also identified that The DBI Calculator 
was considered useful for recognizing sedative and anticholinergic 
medicines in 80% of participants. The average time for participants 
to complete the task was 7 minutes 21 seconds.
Conclusion: We have developed a reliable calculator to report DBI 
in older patients taking multiple medications. Further studies will 
assess application of The DBI Calculator© in clinical settings such 
as pharmacist medication management reviews.
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Introduction: In the United Kingdom, the self-administration of 
prescribed medicines by hospitalized patients has been supported by 
pharmaceutical and nursing bodies. Suggested benefits of self-admin-
istration include greater patient knowledge about their medicines, 
improved concordance with treatment, and increased patient satisfac-
tion. We wished to assess the proportion of medicines administered 
by hospitalized patients and to describe the patient and drug factors 
associated with self-administration.
Patients (or Materials) and Methods: We used data from University 
Hospitals Birmingham NHS Foundation Trust, which uses a locally 
developed electronic prescribing and medication administration sys-
tem known as PICS (Prescribing, Information and Communication 
System). We extracted data from every drug prescription and admin-
istration recorded from January 1, 2012, to December 31, 2012. 
The data were analyzed to ascertain the degree to which patients 
administered their medicines in the hospital. Drug and patient data 
were also extracted to determine the association between these fac-
tors and self-administration.
Results: In the 12-month period analyzed, 45,115 patients were 
admitted to the hospital. During this time period, 657,230 drug pre-
scriptions were recorded, of which 5.8% (38,583) were administered 
by the patient at least once during the course of the prescription. The 
drugs most commonly self-administered were paracetamol, salbu-
tamol, and nystatin. The majority of medicines (14,797 [38.4%]) 
administered by the patient was in a tablet form. Almost two thirds 
(65.4%) of prescriptions identified as the patient’s own were admin-
istered by the patient. The self-administration of medicines occurred 
at least once in a significantly greater proportion of male patients 
(28.9% compared with 27.6%; P = 0.01).
Conclusion: During the 1-year period examined, < 6% of prescribed 
medicines were administered by the patient. These data suggest that 
the focused promotion of self-administration to appropriate patients 
may be necessary. However, it remains unknown to what extent self-
administration could or should be increased, as an evaluation of 
the benefits and potential harms of patients administering their own 
medicines has not yet been undertaken. Further work is also nec-
essary to evaluate the role of electronic prescribing and medicine 
administration systems in supporting the self-administration of medi-
cines in patients where it is safe and appropriate.
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Introduction: Timely administration of medicines in hospital is essen-
tial for optimizing treatment and avoiding unnecessary disruption to 
the patient’s usual routine. The time a medicine is administered to 
a patient can be compared with the time it was due, and used as a 
marker for the quality of medicines provision in a hospital setting.
Patients (or Materials) and Methods: The Prescribing Information 
and Communication System (PICS) is an electronic prescribing and 
medicines administration system in place at the University Hospitals 
Birmingham NHS Foundation Trust. Data from the PICS system 
feeds a database that has been used to audit the timeliness of medi-
cation administration within the Trust. Data are provided for all 
medicines administered > 30 minutes before or > 90 minutes after 
the due time, classified as “not on time” (and noncompliant with 
guidance) and shown on the clinical dashboard. To investigate this 
issue further, data were extracted for a 4-week period between August 
and September 2012 for all “regular” and “one-off” doses (excluding 
infusions). For each administration, the prescribed “due time” was 
noted as well as time that administration was documented to occur.
Results: The audit data demonstrate that just under one half of 
all medicines were administered within the 2-hour time window 
of the prescribed due time. However further analysis of the data 
showed that the majority of medicines were prescribed to be 
administered at 1 of 6 specific times during the day, despite there 
only being 4 main medicine administration rounds carried out 
in any 24-hour period. Specific issues were noted; for example, 
many medicines were prescribed to be administered at midday, a 
time protected for patient meal times and therefore not feasible 
for medicine administration. Documented administration times 
often varied significantly from due times around these round 
intervals.
Conclusion: Overall, the hospital showed poor performance on the 
timely administration of medicines, which was never been much bet-
ter than 50% compliance. Further analysis has shown that for most 
clinical areas, only 4 medicine administration rounds occur, despite 
the prescribed due times of medicines being spread more widely. The 
due times of medicines produced from electronic system defaults and 
their subsequent administration were never designed with this sort 
of monitoring in mind. Capturing these data from the electronic 
prescribing system has highlighted the need to align system design 
with clinical practice.
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